HCA
CDMO

Harbor Capital Advisors’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Harbor Capital Advisors’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,124,351
Closed -$13.9M – 1571
2024
Q4 		$13.9M Buy
1,124,351
+11,759
+1% +$135K 0.61% 25
2024
Q3 		$12.7M Buy
1,112,592
+702,553
+171% +$7.05M 0.55% 39
2024
Q2 		$2.93M Buy
410,039
+310,921
+314% +$2.38M 0.22% 128
2024
Q1 		$664K Buy
+99,118
New +$682K 0.09% 310

Other funds holding CDMO

TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Harbor Capital Advisors's CDMO Position: Q1 2025 in Review

Harbor Capital Advisors sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 1,124,351 shares — an estimated $13.9M sold.

Harbor Capital Advisors first reported a position in CDMO in Q1 2024 and held it in 4 quarters. The position peaked at $13.9M in Q4 2024. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • Harbor Capital Advisors reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Harbor Capital Advisors sold 1,124,351 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $13.9M.
  • Harbor Capital Advisors first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2024 and held it in 4 quarters.
  • Harbor Capital Advisors's Avid Bioservices, Inc. Common Stock position peaked at $13.9M in Q4 2024.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Harbor Capital Advisors's 13F filing for Q1 2025, filed 14 Apr 2025.